The results of several studies suggest that, apart from their direct effect on tumor cells, CDK4/6is influence immune cells in the TME [28–30], including the suppression of regulatory T cell proliferation and enhanced activation of tumor-infiltrating lymphocytes (TILs) [31]. This evidence concerns the gene CDK4 and neoplasm.